You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
TEMODAL capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. TEMODAL capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.
Size No 3 capsule with opaque green cap and opaque white body containing a white to light pink, light tan powder. Cap is imprinted in black ink with "TEMODAL", the body is imprinted in black ink with two stripes; "5 mg" and the Schering-Plough logo.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
TEMODAL capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. TEMODAL capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.
Size No 2 capsule with yellow cap and opaque white body containing a white to light pink, light tan powder. The cap is imprinted in black ink with "TEMODAL", the body is imprinted in black ink with two stripes; "20 mg" and the Schering-Plough logo.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
TEMODAL capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. TEMODAL capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.
Size No 1 capsule with opaque pink cap and opaque white body containing a white to light pink, light tan powder. The cap is imprinted in black ink with TEMODAL, the body is imprinted in black ink with two stripes; 100 mg and the Schering-Plough logo.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Temodal capsules are indicated for the treatment of : patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. Temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.
size no. 0 capsule with a blue cap and white opaque body containing a white to light pink, light tan powder. The cap is imprinted in black with TEMODAL, the body is imprinted in black with 2 stripes, 140 mg and the SP logo.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
TEMODAL capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. TEMODAL capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.
Size No 1 capsule with opaque pink cap and opaque white body containing a white to light pink, light tan powder. The cap is imprinted in black ink with TEMODAL, the body is imprinted in black ink with two stripes; 100 mg and the Schering-Plough logo.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Temodal capsules are indicated for the treatment of : patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. Temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.
size no. 0 capsule with a orange cap and white opaque body containing a white to light pink, light tan powder. The cap is imprinted in black with TEMODAL, the body is imprinted in black with 2 stripes, 180 mg and the SP logo.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
